Literature DB >> 31375590

A Redundant Mechanism of Recruitment Underlies the Remarkable Plasticity of the Requirement of Poliovirus Replication for the Cellular ArfGEF GBF1.

Ekaterina G Viktorova1, Samuel Gabaglio1, Justyna M Meissner2, Eunjoo Lee2, Seyedehmahsa Moghimi1, Elizabeth Sztul2, George A Belov3.   

Abstract

The replication of many positive-strand RNA viruses [(+)RNA viruses] depends on the cellular protein GBF1, but its role in the replication process is not clear. In uninfected cells, GBF1 activates small GTPases of the Arf family and coordinates multiple steps of membrane metabolism, including functioning of the cellular secretory pathway. The nonstructural protein 3A of poliovirus and related viruses has been shown to directly interact with GBF1, likely mediating its recruitment to the replication complexes. Surprisingly, viral mutants with a severely reduced level of 3A-GBF1 interaction demonstrate minimal replication defects in cell culture. Here, we systematically investigated the conserved elements of GBF1 to understand which determinants are important to support poliovirus replication. We demonstrate that multiple GBF1 mutants inactive in cellular metabolism could still be fully functional in the replication complexes. Our results show that the Arf-activating property, but not the primary structure of the Sec7 domain, is indispensable for viral replication. They also suggest a redundant mechanism of recruitment of GBF1 to the replication sites, which is dependent not only on direct interaction of the protein with the viral protein 3A but also on determinants located in the noncatalytic C-terminal domains of GBF1. Such a double-targeting mechanism explains the previous observations of the remarkable tolerance of different levels of GBF1-3A interaction by the virus and likely constitutes an important element of the resilience of viral replication.IMPORTANCE Enteroviruses are a vast group of viruses associated with diverse human diseases, but only two of them could be controlled with vaccines, and effective antiviral therapeutics are lacking. Here, we investigated in detail the contribution of a cellular protein, GBF1, in the replication of poliovirus, a representative enterovirus. GBF1 supports the functioning of cellular membrane metabolism and is recruited to viral replication complexes upon infection. Our results demonstrate that the virus requires a limited subset of the normal GBF1 functions and reveal the elements of GBF1 essential to support viral replication under different conditions. Since diverse viruses often rely on the same cellular proteins for replication, understanding the mechanisms by which these proteins support infection is essential for the development of broad-spectrum antiviral therapeutics.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Arf activation; ArfGEF; GBF1; poliovirus; replication organelles

Mesh:

Substances:

Year:  2019        PMID: 31375590      PMCID: PMC6803275          DOI: 10.1128/JVI.00856-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Structural snapshots of the mechanism and inhibition of a guanine nucleotide exchange factor.

Authors:  Louis Renault; Bernard Guibert; Jacqueline Cherfils
Journal:  Nature       Date:  2003-12-04       Impact factor: 49.962

2.  Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo.

Authors:  Bakhos A Tannous; Dong-Eog Kim; Juliet L Fernandez; Ralph Weissleder; Xandra O Breakefield
Journal:  Mol Ther       Date:  2005-03       Impact factor: 11.454

3.  Production of monoclonal and monospecific antibodies against non-capsid proteins of poliovirus.

Authors:  L Pasamontes; D Egger; K Bienz
Journal:  J Gen Virol       Date:  1986-11       Impact factor: 3.891

4.  Enterovirus 3A Facilitates Viral Replication by Promoting Phosphatidylinositol 4-Kinase IIIβ-ACBD3 Interaction.

Authors:  Xia Xiao; Xiaobo Lei; Zhenzhen Zhang; Yijie Ma; Jianli Qi; Chao Wu; Yan Xiao; Li Li; Bin He; Jianwei Wang
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

5.  Poliovirus Replicon RNA Generation, Transfection, Packaging, and Quantitation of Replication.

Authors:  Ekaterina G Viktorova; Sunil Khattar; Siba Samal; George A Belov
Journal:  Curr Protoc Microbiol       Date:  2018-02-22

6.  Highly conserved motifs within the large Sec7 ARF guanine nucleotide exchange factor GBF1 target it to the Golgi and are critical for GBF1 activity.

Authors:  Cristian A Pocognoni; Ekaterina G Viktorova; John Wright; Justyna M Meissner; Garrett Sager; Eunjoo Lee; George A Belov; Elizabeth Sztul
Journal:  Am J Physiol Cell Physiol       Date:  2018-02-14       Impact factor: 4.249

7.  Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral infection.

Authors:  D A Dodd; T H Giddings; K Kirkegaard
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 8.  Regulation of Arf activation: the Sec7 family of guanine nucleotide exchange factors.

Authors:  James E Casanova
Journal:  Traffic       Date:  2007-09-10       Impact factor: 6.215

9.  A novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase IIIβ.

Authors:  Hilde M van der Schaar; Pieter Leyssen; Hendrik J Thibaut; Armando de Palma; Lonneke van der Linden; Kjerstin H W Lanke; Céline Lacroix; Erik Verbeken; Katja Conrath; Angus M Macleod; Dale R Mitchell; Nicholas J Palmer; Hervé van de Poël; Martin Andrews; Johan Neyts; Frank J M van Kuppeveld
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

10.  Mouse hepatitis coronavirus RNA replication depends on GBF1-mediated ARF1 activation.

Authors:  Monique H Verheije; Matthijs Raaben; Muriel Mari; Eddie G Te Lintelo; Fulvio Reggiori; Frank J M van Kuppeveld; Peter J M Rottier; Cornelis A M de Haan
Journal:  PLoS Pathog       Date:  2008-06-13       Impact factor: 6.823

View more
  7 in total

1.  Foot-and-Mouth Disease Virus 3A Hijacks Sar1 and Sec12 for ER Remodeling in a COPII-Independent Manner.

Authors:  Heng-Wei Lee; Yi-Fan Jiang; Hui-Wen Chang; Ivan-Chen Cheng
Journal:  Viruses       Date:  2022-04-18       Impact factor: 5.818

2.  Enterovirus Infection Induces Massive Recruitment of All Isoforms of Small Cellular Arf GTPases to the Replication Organelles.

Authors:  Seyedehmahsa Moghimi; Ekaterina Viktorova; Anna Zimina; Tomasz Szul; Elizabeth Sztul; George A Belov
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

3.  A miRNA screen procedure identifies garz as an essential factor in adult glia functions and validates Drosophila as a beneficial 3Rs model to study glial functions and GBF1 biology.

Authors:  Catarina Gonçalves-Pimentel; David Mazaud; Benjamin Kottler; Sandra Proelss; Frank Hirth; Manolis Fanto
Journal:  F1000Res       Date:  2020-05-01

Review 4.  Picornaviruses: A View from 3A.

Authors:  Terry Jackson; Graham J Belsham
Journal:  Viruses       Date:  2021-03-11       Impact factor: 5.048

5.  Secretory Carrier Membrane Protein 3 Interacts with 3A Viral Protein of Enterovirus and Participates in Viral Replication.

Authors:  Jia-Ying Lu; Gary Brewer; Mei-Ling Li; Kai-Zhe Lin; Chien-Chih Huang; Li-Chen Yen; Jing-Yi Lin
Journal:  Microbiol Spectr       Date:  2021-08-11

6.  Characterization of the c10orf76-PI4KB complex and its necessity for Golgi PI4P levels and enterovirus replication.

Authors:  Jacob A McPhail; Heyrhyoung Lyoo; Joshua G Pemberton; Reece M Hoffmann; Wendy van Elst; Jeroen R P M Strating; Meredith L Jenkins; Jordan T B Stariha; Cameron J Powell; Martin J Boulanger; Tamas Balla; Frank J M van Kuppeveld; John E Burke
Journal:  EMBO Rep       Date:  2019-12-12       Impact factor: 8.807

7.  ARF1 with Sec7 Domain-Dependent GBF1 Activates Coatomer Protein I To Support Classical Swine Fever Virus Entry.

Authors:  Liang Zhang; Tao Wang; Yanyan Yi; Mengzhao Song; Mingxing Jin; Kangkang Guo; Yanming Zhang
Journal:  J Virol       Date:  2022-01-19       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.